Aceragen

About:

Aceragen is a developer of therapeutic treatments intended for rare and ultra-rare diseases.

Website: https://www.aceragen.com/

Twitter/X: aceragen

Top Investors: Novaquest Capital Management

Description:

Aceragen is a developer of therapeutic treatments intended for rare and ultra-rare diseases.

Total Funding Amount:

$35M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)aceragen.com

Founders:

John Taylor

Number of Employees:

11-50

Last Funding Date:

2021-05-03

IPO Status:

Private

Industries: